Following eyonis® LCS' FDA 510 (k) clearance announced on February 9, 2026, Median has activated a phased U.S. launch strategy designed for disciplined national expansion. The Company has conducted ...
Colorectal cancer is the second leading cause of cancer-related deaths for males and females. Screening for colorectal cancer is an effective strategy to reduce morbidity and mortality. The ...
Low-dose computed tomography (LDCT) screening is effective in reducing lung cancer mortality by detecting the disease at earlier, more treatable stages. However, high false-positive rates and the ...
Hosted on MSN
'A second set of eyes': AI-supported breast cancer screening spots more cancers earlier, landmark trial finds
A first-of-its-kind trial demonstrates that AI-assisted mammography can improve the outcomes of patients with breast cancer, particularly those with aggressive disease. While many people have only ...
SAN DIEGO — In the ever-expanding options for colorectal cancer (CRC) screening, blood tests using precision medicine are becoming more advanced and convenient than ever; however, caveats abound, and ...
Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. Lung cancer screening remains strikingly underused, with ...
Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing ...
A Swedish study finds AI-supported screening detects 29% more cancers without increasing false positives, while cutting radiologists’ workload by 44%. Study: Screening performance and characteristics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results